| 2026-08-12 | Presentation | PTC Therapeutics Fabry Disease Transaction Call FLS |
| 2026-08-12 | Press release | PTC to Expand Rare Disease Portfolio with Acquisition of BLA-Stage ST-920 Fabry Disease Program |
| 2026-07-30 | Presentation | PTC Corporate Presentation – July 2026 |
| 2026-07-30 | Press release | PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results |
| 2026-07-16 | Press release | PTC Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, July 30, 2026 |
| 2026-06-17 | Press release | PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-06-15 | Press release | PTC Therapeutics Announces Proposed Convertible Notes Offering to Refinance 2026 Convertible Notes |
| 2026-06-15 | Press release | PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes |
| 2026-05-07 | Quarterly report | Q1 2026 FLS |
| 2026-05-07 | Press release | PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results |
| 2026-05-04 | Press release | PTC Therapeutics to Participate in Upcoming Investor Conferences |
| 2026-04-28 | Press release | PTC Therapeutics Reports Positive Topline Results from Month 24 Interim Analysis of PIVOT-HD Extension Study of Votoplam |
| 2026-04-28 | Press release | PTC Therapeutics to Report Results from PIVOT-HD Long Term Extension Study |
| 2026-04-22 | Press release | PTC Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026 |
| 2026-04-17 | Press release | PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-03-25 | Press release | PTC Therapeutics Appoints Biotech Banking Pioneer Jessica Chutter to Board of Directors |
| 2026-03-13 | Press release | PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-02-23 | Press release | PTC Therapeutics to Participate at Upcoming Investor Conferences |
| 2026-02-19 | Press release | PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results |
| 2026-02-12 | Press release | PTC Therapeutics Provides Regulatory Update on Translarna™ |
| 2026-02-05 | Press release | PTC Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, Feb. 19, 2026 |
| 2026-01-12 | Press release | PTC Therapeutics Provides Update at J.P. Morgan Annual Healthcare Conference |
| 2026-01-08 | Press release | PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2025-12-02 | Presentation | View Presentation |
| Press release | PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results |
| 2025-02-27 | Press release | PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results |
| 2024-11-07 | Press release | PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results |
| 2024-10-24 | Press release | PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2024 Financial Results |
| 2024-08-08 | Press release | PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results |
| 2024-07-25 | Press release | PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results |
| 2024-04-25 | Press release | PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results |
| 2024-04-11 | Press release | PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results |
| 2024-02-29 | Press release | PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results |
| 2024-02-15 | Press release | PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results |
| 2023-07-19 | Presentation | PKU Deep Dive Presentation |
| 2023-05-23 | Earnings deck | MOVE-FA Topline Results Presentation |
| 2023-05-01 | Presentation | APHENITY Topline Results Updated Presentation |
| Press release | PTC Therapeutics to Present at the Jefferies Virtual Gene Therapy/Editing Summit |
| Press release | PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year-End 2019 Financial Results |
| Press release | PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2020 Financial Results |